Position in NVS
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$322,529
+$8,170 QoQ
Shares Held
2,058
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1,090
of 1,603 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Keudell/Morrison Wealth Management holds $22,085,611 across 13 Drug Manufacturers - General names. NVS ranks #13 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,989 | $5,983,956 | |
| 2 | ABBV |
AbbVie Inc.
|
20,064 | $5,048,904 | |
| 3 | JNJ |
Johnson & Johnson
|
7,437 | $1,888,774 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
14,835 | $1,874,253 | |
| 5 | AMGN |
Amgen Inc
|
4,952 | $1,793,218 | |
| 6 | MRK |
Merck & Co., Inc.
|
13,268 | $1,704,938 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,945 | $1,149,230 | |
| 8 | SNY |
Sanofi
|
14,344 | $611,915 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $322,529 | 2,058 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $314,359 | 2,058 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $276,842 | 2,008 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $342,216 | 2,828 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $315,265 | 2,828 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $265,072 | 2,724 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $312,509 | 2,717 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $297,129 | 2,791 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $282,161 | 2,917 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $318,863 | 3,158 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $320,044 | 3,142 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $320,994 | 3,181 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $301,668 | 3,279 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $297,470 | 3,279 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $256,077 | 3,369 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $271,003 | 3,206 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $361,354 | 4,118 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $331,598 | 3,791 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $322,785 | 3,947 | Shares | Sole | 2021-12-08 | |
| 2021-06-30 | $335,671 | 3,679 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $299,180 | 3,500 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $326,444 | 3,457 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $305,577 | 3,514 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $333,900 | 3,823 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $262,191 | 3,180 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||